Several methods have been applied to target TAMs or ATMs to prevent tumor growth or inflammation, such as macrophage depletion, blockade of anti-phagocytic signaling (e.g., Siglec-10 or SIRPα). The gene discussed is SIRPA; the disease is neoplasm.